JP2009518337A5 - - Google Patents

Download PDF

Info

Publication number
JP2009518337A5
JP2009518337A5 JP2008543720A JP2008543720A JP2009518337A5 JP 2009518337 A5 JP2009518337 A5 JP 2009518337A5 JP 2008543720 A JP2008543720 A JP 2008543720A JP 2008543720 A JP2008543720 A JP 2008543720A JP 2009518337 A5 JP2009518337 A5 JP 2009518337A5
Authority
JP
Japan
Prior art keywords
piperidine
disorder
group
compound
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008543720A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009518337A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/011712 external-priority patent/WO2007065655A1/en
Publication of JP2009518337A publication Critical patent/JP2009518337A/ja
Publication of JP2009518337A5 publication Critical patent/JP2009518337A5/ja
Abandoned legal-status Critical Current

Links

JP2008543720A 2005-12-07 2006-12-06 皮質カテコールアミン作動性神経伝達のモジュレーターとしての二置換フェニルピペリジン Abandoned JP2009518337A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74807705P 2005-12-07 2005-12-07
SE0502709 2005-12-07
PCT/EP2006/011712 WO2007065655A1 (en) 2005-12-07 2006-12-06 Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission

Publications (2)

Publication Number Publication Date
JP2009518337A JP2009518337A (ja) 2009-05-07
JP2009518337A5 true JP2009518337A5 (enExample) 2010-02-04

Family

ID=37909741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008543720A Abandoned JP2009518337A (ja) 2005-12-07 2006-12-06 皮質カテコールアミン作動性神経伝達のモジュレーターとしての二置換フェニルピペリジン

Country Status (4)

Country Link
US (1) US20080269286A1 (enExample)
EP (1) EP1963268B1 (enExample)
JP (1) JP2009518337A (enExample)
WO (1) WO2007065655A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
US7851629B2 (en) 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
SE0401465D0 (sv) 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
DE602005021641D1 (de) 2004-06-08 2010-07-15 Nsab, Filial Af Neurosearch Sweden Ab Neue disubstituierte phenylpiperidine und piperazine als modulatoren der dopamin-neurotransmission
ES2659577T3 (es) 2004-10-13 2018-03-16 Teva Pharmaceuticals International Gmbh Proceso para la síntesis de 4-(3-metanosulfonilfenil)-1-N-propil-piperidina
SE529246C2 (sv) 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
UY34503A (es) 2011-12-08 2013-07-31 Ivax Int Gmbh ?sal de bromhidrato de pridopidina?
US20130267552A1 (en) 2012-04-04 2013-10-10 IVAX International GmbH Pharmaceutical compositions for combination therapy
HUE049278T2 (hu) 2014-08-15 2020-09-28 Janssen Pharmaceuticals Inc Pirazolok
US11220487B2 (en) * 2017-06-14 2022-01-11 Bayer Aktiengesellschaft Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1459013A (fr) * 1964-08-05 1966-04-29 Allen & Hanburys Ltd Procédé de préparation de dérivés de la 4-phényl-pipéridine
US4415736A (en) 1981-12-28 1983-11-15 E. I. Du Pont De Nemours & Co. Certain tetrahydropyridine intermediates
US5658590A (en) 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
DE69817557T2 (de) 1997-05-14 2004-06-17 Neurosearch A/S Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme
IL146564A0 (en) * 1999-05-24 2002-07-25 Mitsubishi Pharma Corp Phenoxypropylamine derivatives and pharmaceutical compositions containing the same
SE9904723D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
SE9904724D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
US20080318999A1 (en) * 2005-08-05 2008-12-25 Methvin Isaac Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators

Similar Documents

Publication Publication Date Title
JP2009518337A5 (enExample)
JP2010529081A5 (enExample)
RU2010119560A (ru) Замещенные n-фенилбипирролидинкарбоксамиды и их терапевтическое применение
RU2470011C2 (ru) Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
RU2005128775A (ru) Производные пиперидинбензолсульфамида
JP2007502265A5 (enExample)
RU2471781C2 (ru) Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
JP2017535559A5 (enExample)
JP2011530521A5 (enExample)
RU2010119554A (ru) Замещенные n-фенил-бипирролидинмочевины и их терапевтическое применение
IL276946B (en) Antiproliferative compounds and methods of use thereof
JP2016169231A (ja) Mglur5の負のアロステリック調節剤としての6−アルキル−n−(ピリジン−2−イル)−4−アリールオキシピコリンアミド類似体ならびにそれを作製および使用する方法
JP2011524336A5 (enExample)
CA2389300A1 (en) 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
JP2011500696A5 (enExample)
JP2010539119A5 (enExample)
JP2007508360A5 (enExample)
CA2713025A1 (en) Kappa selective opioid receptor antagonist
RU2005128556A (ru) Гетероциклил-3-сульфонилиндазолы в качестве лигандов 5-гидрокситриптамина-6
JP2006502119A5 (enExample)
JP2010523623A5 (enExample)
CN1127114A (zh) 取代的4-苯基-6-氨基烟酸衍生物作为药物的应用
JP2017502063A5 (enExample)
HRP20110226T1 (hr) Derivati piperidin-4-il-piridazin-3-ilamina kao brzo disocirajući antagonisti dopamin 2 receptora